| ACovPid | Against Virus | Inhibition Value Type | Inhibitory Effect | Inhibitory Unit | Target Domain Name | Detail |
|---|---|---|---|---|---|---|
| ACoVP100341 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.993 ± 0.08 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100342 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 1.738 ± 0.898 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100343 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >25 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100344 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >50 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100345 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.251 ± 0.118 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100346 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 1.315 ± 0.463 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100347 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 1.053 ± 0.444 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100348 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >25 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100349 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >25 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100350 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 1.037 ± 0.836 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100351 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 1.13 ± 0.472 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100352 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >25 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100353 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 6.2 | µg/mL | more | |
| ACoVP100354 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 4.2 | µg/mL | more | |
| ACoVP100355 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 2.4 | µg/mL | more | |
| ACoVP100356 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 0.9 | µg/mL | more | |
| ACoVP100357 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 8.8 | µg/mL | more | |
| ACoVP100358 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 2.2 | µg/mL | more | |
| ACoVP100359 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 20.2 | µg/mL | more | |
| ACoVP100360 | Human coronavirus 229E (HCoV-229E) : 11137 | IC50 | 5.7 | µM | HR1 domain of HCoV-229E | more |